The motivation of this article is to address the ambivalent position of policy analysis when it intervenes in the real-world policy process through policy evaluation. It tackles the underresearched question of the challenges faced by policy analysis in relation to applied research mandates. It argues that policy analysis is constantly at risk of instrumentalisation by politico-administrative players. The article is based on the evaluation of the medical cannabis policy in Switzerland as a case study. The results point out four specific challenges faced by applied policy analysis: political pressure, scientific integrity, access to sensitive data, and epistemic legitimacy. However, applied policy analysis can contribute to de-escalating controversies by presenting a bigger and contextualised picture of the considered political issues. Policy evaluation can identify deficient implementation processes, but also wider mismatches among legislative and societal processes. Hence, although evidence is subordinated to other factors in the decision-making process, evaluations provide an outside perspective, which can help solving controversies around policies. The article contributes to the literature on the politics of policy analysis by showing that confronting policy analysis with practical problems brings both scientific and policy benefits.
机构:
Univ Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USAUniv Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USA
Basu, Anirban
Axelsen, Kirsten
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Inc, New York, NY USAUniv Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USA
Axelsen, Kirsten
Grabowski, David C.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USAUniv Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USA
Grabowski, David C.
Meltzer, David O.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Chicago, Dept Med, Chicago, IL 60637 USA
Univ Chicago, Dept Econ, Chicago, IL 60637 USA
Univ Chicago, Sch Publ Policy Studies, Chicago, IL 60637 USAUniv Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USA
Meltzer, David O.
Polsky, Daniel
论文数: 0引用数: 0
h-index: 0
机构:
Univ Penn, Wharton Sch, Dept Med, Philadelphia, PA 19104 USA
Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USAUniv Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USA
Polsky, Daniel
Ridley, David B.
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Fuqua Sch Business, Durham, NC 27706 USAUniv Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USA
Ridley, David B.
Wiederkehr, Daniel
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Inc, New York, NY USAUniv Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USA
Wiederkehr, Daniel
Philipson, Tomas J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Chicago, Harris Sch Publ Policy Studies, Chicago, IL 60637 USAUniv Washington, Dept Pharm, Pharmaceut Outcome Res & Policy Program, Seattle, WA 98195 USA